Biosens Labssp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 380 days for 2023).
- 202512/08/2026
- 202430/07/2025
- 202330/07/2025
- 202213/07/2023
- 202109/10/2022
- 202029/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksandra Maria Burzyńskaage 45 | 79 | $1,066.99 | 69.9115% |
Others | 34 | $459.21 | 30.0885% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-08-05.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2021 | Aid for research and development projects: experimental development | $288.1K$288,093 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 20, 2021 | Aid for research and development projects: industrial research | $178.5K$178,468 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-08-01 | Conducting research and development work to develop an innovative set of bioreceptors for detecting the SARS-CoV-2 virus in POCT systems using phage peptide library technology | $466.6K$466,560 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Spektrinosp. z o.o. | $21,528.32 | spektrino.com | ||
| Unidectsp. z o.o. | $21,242.17 | univect.com | ||
| Braintechsp. z o.o. | $20,965.65 | braintech.pl | ||
| 2loop TechS.A. | $15,564.71 | 2loop.tech | ||
| HTPsp. z o.o. | $13,728.34 | htp7.pl | ||
| Renewablepowersp. z o.o. | $11,568.22 | renewablepower.pl | ||
| Microanalysissp. z o.o. | $1,425.98 | microanalysis.pl | ||
| DEEP Technologysp. z o.o. | $1,202.71 | deeptechnology.ai | ||
| Microbiota Medsp. z o.o. | $916.10 | microbiota-med.com | ||
| Nevomo Iotsp. z o.o. | $502.62 | nevomo.tech |
Change history
| Date | Event | |
|---|---|---|
| 2021-01-19 | Share capital increase (5,000.00 PLN → 5,650.00 PLN) | |
| 2020-06-01 | Entered in the register |
FAQ
Last updated: 2026-10-07